Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

PMID: 28151388
Journal: Blood Transfusion
Year: 2017
Reference: Blood Transfus. 2017 Jul;15(4):296-306. doi: 10.2450/2017.0177-16. Epub 2017 Jan 26.
Impact factor: 1.607
Publication type: Review in national publication
Authors: Bisbe, Elvira, Basora, Misericordia, Colomina, Maria J et al.
DOI: 10.2450/2017.0177-16

Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

PMID: 28151388
Journal: Blood Transfusion
Year: 2017
Reference: Blood Transfus. 2017 Jul;15(4):296-306. doi: 10.2450/2017.0177-16. Epub 2017 Jan 26.
Impact factor:
Publication type: Review in national publication
Authors: Basora, Misericordia; Bisbe, Elvira; Colomina, Maria J et al.
DOI: 10.2450/2017.0177-16

Peripheral levels of BDNF and opiate-use disorder: literature review and update.

PMID: 28306543
Journal: REVIEWS IN THE NEUROSCIENCES
Year: 2017
Reference: Rev Neurosci. 2017 Jul 26;28(5):499-508. doi: 10.1515/revneuro-2016-0078.
Impact factor: 2.546
Publication type: Review in international publication
Authors: Palma-Alvarez, Raul Felipe, Ros-Cucurull, Elena, Amaro-Hosey, Kristopher, Rodriguez-Cintas, Laia, Grau-Lopez, Lara, Corominas-Roso, Margarida, Sanchez-Mora, Cristina, Roncero, Carlos et al.
DOI: 10.1515/revneuro-2016-0078

Peripheral levels of BDNF and opiate-use disorder: literature review and update.

PMID: 28306543
Journal: REVIEWS IN THE NEUROSCIENCES
Year: 2017
Reference: Rev Neurosci. 2017 Jul 26;28(5):499-508. doi: 10.1515/revneuro-2016-0078.
Impact factor:
Publication type: Review in international publication
Authors: Amaro-Hosey, Kristopher; Corominas-Roso, Margarida; Grau-Lopez, Lara; Palma-Alvarez, Raul Felipe; Palma-Alvarez, Raul Felipe; Rodriguez-Cintas, Laia; Roncero, Carlos; Ros-Cucurull, Elena; Sanchez-Mora, Cristina et al.
DOI: 10.1515/revneuro-2016-0078

Peripheral nervous system involvement in multiple sclerosis.

PMID: 28185471
Journal: Multiple Sclerosis Journal
Year: 2017
Reference: Mult Scler. 2017 Apr;23(5):751. doi: 10.1177/1352458517693469. Epub 2017 Feb 10.
Impact factor: 4.84
Publication type: Review in international publication
Authors: Rovira, Alex et al.
DOI: 10.1177/1352458517693469

Peripheral nervous system involvement in multiple sclerosis.

PMID: 28185471
Journal: Multiple Sclerosis Journal
Year: 2017
Reference: Mult Scler. 2017 Apr;23(5):751. doi: 10.1177/1352458517693469. Epub 2017 Feb 10.
Impact factor:
Publication type: Review in international publication
Authors: Rovira, Alex et al.
DOI: 10.1177/1352458517693469

Periprosthetic joint infection by Propionibacterium acnes: Clinical differences between monomicrobial versus polymicrobial infection.

PMID: 28285096
Journal: ANAEROBE
Year: 2017
Reference: Anaerobe. 2017 Apr;44:143-149. doi: 10.1016/j.anaerobe.2017.03.008. Epub 2017 Mar 8.
Impact factor: 2.278
Publication type: Paper in international publication
Authors: Gomez, Lucia, Matamala, A, Lung, Mayli, Cuchi, Eva, Corona, Pablo S, Muneton, David, Figa, Raul et al.
DOI: 10.1016/j.anaerobe.2017.03.008

Periprosthetic joint infection by Propionibacterium acnes: Clinical differences between monomicrobial versus polymicrobial infection.

PMID: 28285096
Journal: ANAEROBE
Year: 2017
Reference: Anaerobe. 2017 Apr;44:143-149. doi: 10.1016/j.anaerobe.2017.03.008. Epub 2017 Mar 8.
Impact factor:
Publication type: Paper in international publication
Authors: Corona, Pablo S; Cuchi, Eva; Figa, Raul; Gomez, Lucia; Lung, Mayli; Matamala, A; Muneton, David et al.
DOI: 10.1016/j.anaerobe.2017.03.008

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

PMID: 26810137
Journal: PHARMACOGENOMICS JOURNAL
Year: 2017
Reference: Pharmacogenomics J. 2017 Jan;17(1):98-104. doi: 10.1038/tpj.2015.89. Epub 2016 Jan 26.
Impact factor: 3.815
Publication type: Paper in international publication
Authors: Pagerols, M, Richarte, V, Sanchez-Mora, C, Garcia-Martinez, I, Corrales, M, Corominas, M, Cormand, B, Ribases, M, Ramos-Quiroga, J A, Casas, M et al.
DOI: 10.1038/tpj.2015.89

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

PMID: 26810137
Journal: PHARMACOGENOMICS JOURNAL
Year: 2017
Reference: Pharmacogenomics J. 2017 Jan;17(1):98-104. doi: 10.1038/tpj.2015.89. Epub 2016 Jan 26.
Impact factor:
Publication type: Paper in international publication
Authors: Casas, M; Cormand, B; Corominas, M; Corrales, M; Garcia-Martinez, I; Pagerols, M; Ramos-Quiroga, J A; Ribases, M; Richarte, V; Sanchez-Mora, C et al.
DOI: 10.1038/tpj.2015.89

PHARMACOKINETIC AND TISSUE DISTRIBUTION OF BENZNIDAZOLE AFTER ORAL ADMINISTRATION IN MICE.

PMID: 28167558
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.02410-16. doi: 10.1128/AAC.02410-16. Print 2017 Apr.
Impact factor: 4.302
Publication type: Paper in international publication
Authors: Perin, Luisa, Moreira da Silva, Rodrigo, da Silva Fonseca, Katia, Mirelle de Oliveira Cardoso, Jamille, Mathias, Fernando Augusto Siqueira, Reis, Levi Eduardo Soares, Molina, Israel, Correa-Oliveira, Rodrigo, de Abreu Vieira, Paula Melo, Carneiro, Claudia Martins et al.
DOI: 10.1128/AAC.02410-16

PHARMACOKINETIC AND TISSUE DISTRIBUTION OF BENZNIDAZOLE AFTER ORAL ADMINISTRATION IN MICE.

PMID: 28167558
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.02410-16. doi: 10.1128/AAC.02410-16. Print 2017 Apr.
Impact factor:
Publication type: Paper in international publication
Authors: Carneiro, Claudia Martins; Correa-Oliveira, Rodrigo; da Silva Fonseca, Katia; de Abreu Vieira, Paula Melo; Mathias, Fernando Augusto Siqueira; Mirelle de Oliveira Cardoso, Jamille; Molina, Israel; Moreira da Silva, Rodrigo; Perin, Luisa; Reis, Levi Eduardo Soares et al.
DOI: 10.1128/AAC.02410-16

Pharmacokinetic of benznidazole in healthy volunteers: Implications in future clinical trials.

PMID: 28167552
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.01912-16. doi: 10.1128/AAC.01912-16. Print 2017 Apr.
Impact factor: 4.302
Publication type: Paper in international publication
Authors: Pedraz, J L, Pinto, L, Esquisabel, A, Perin, L, Molina, I, Salvador, F, Sanchez-Montalva, A, Artaza, M A, Moreno, R et al.
DOI: 10.1128/AAC.01912-16

Pharmacokinetic of benznidazole in healthy volunteers: Implications in future clinical trials.

PMID: 28167552
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.01912-16. doi: 10.1128/AAC.01912-16. Print 2017 Apr.
Impact factor:
Publication type: Paper in international publication
Authors: Artaza, M A; Esquisabel, A; Molina, I; Moreno, R; Pedraz, J L; Perin, L; Pinto, L; Salvador, F; Sanchez-Montalva, A et al.
DOI: 10.1128/AAC.01912-16

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology.

PMID: 28561730
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annua
Year: 2017
Reference: Am Soc Clin Oncol Educ Book. 2017;37:210-215. doi: 10.1200/EDBK_180460.
Impact factor: 0
Publication type: Editorail in international publication
Authors: Garralda, Elena, Dienstmann, Rodrigo, Tabernero, Josep et al.
DOI: 10.1200/EDBK_180460

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology.

PMID: 28561730
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annua
Year: 2017
Reference: Am Soc Clin Oncol Educ Book. 2017;37:210-215. doi: 10.1200/EDBK_180460.
Impact factor:
Publication type: Editorail in international publication
Authors: Dienstmann, Rodrigo; Garralda, Elena; Tabernero, Josep et al.
DOI: 10.1200/EDBK_180460

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

PMID: 28045651
Journal: Farmacia hospitalaria : organo oficial de expresio
Year: 2017
Reference: Farm Hosp. 2017 Jan 1;41(n01):31-48. doi: 10.7399/fh.2017.41.1.10463.
Impact factor: 0
Publication type: Paper in international publication
Authors: Calleja Hernandez, Miguel Angel, Herrero Ambrosio, Alicia, Lamas Diaz, Maria Jesus, Martinez Cutillas, Julio, Aragon, Belen, Poveda Andres, Jose Luis et al.
DOI: 10.7399/fh.2017.41.1.10463

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

PMID: 28045651
Journal: Farmacia hospitalaria : organo oficial de expresio
Year: 2017
Reference: Farm Hosp. 2017 Jan 1;41(n01):31-48. doi: 10.7399/fh.2017.41.1.10463.
Impact factor:
Publication type: Paper in international publication
Authors: Aragon, Belen; Calleja Hernandez, Miguel Angel; Herrero Ambrosio, Alicia; Lamas Diaz, Maria Jesus; Martinez Cutillas, Julio; Poveda Andres, Jose Luis et al.
DOI: 10.7399/fh.2017.41.1.10463

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.

PMID: 28600476
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Sep 15;23(18):5406-5415. doi: 10.1158/1078-0432.CCR-17-0812. Epub 2017 Jun 9.
Impact factor: 9.619
Publication type: Paper in international publication
Authors: Thomas, Marlene, Meulendijks, Didier, Jacob, Wolfgang, Voest, Emile E, Mau-Sorensen, Morten, Martinez-Garcia, Maria, Taus, Alvaro, Fleitas, Tania, Cervantes, Andres, Lolkema, Martijn P et al.
DOI: 10.1158/1078-0432.CCR-17-0812

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.

PMID: 28600476
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Sep 15;23(18):5406-5415. doi: 10.1158/1078-0432.CCR-17-0812. Epub 2017 Jun 9.
Impact factor:
Publication type: Paper in international publication
Authors: Adessi, Celine; Bossenmaier, Birgit; Calles, Antonio; Ceppi, Maurizio; Cervantes, Andres; De Jonge, Maja J; Dua, Rajiv; Felip, Enriqueta; Fleitas, Tania; Han, Ji-Youn et al.
DOI: 10.1158/1078-0432.CCR-17-0812

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

PMID: 28609226
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13.
Impact factor: 24.008
Publication type: Paper in international publication
Authors: Peters, Solange, Gettinger, Scott, Johnson, Melissa L, Janne, Pasi A, Garassino, Marina C, Christoph, Daniel, Toh, Chee Keong, Rizvi, Naiyer A, Chaft, Jamie E, Carcereny Costa, Enric et al.
DOI: 10.1200/JCO.2016.71.9476

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

PMID: 28609226
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13.
Impact factor:
Publication type: Paper in international publication
Authors: Carcereny Costa, Enric; Chaft, Jamie E; Chow, Laura Q M; Christoph, Daniel; Felip, Enriqueta; Fruh, Martin; Garassino, Marina C; Gettinger, Scott; Ho, Cheryl; Janne, Pasi A et al.
DOI: 10.1200/JCO.2016.71.9476

Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA.

PMID: 28809610
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15.
Impact factor: 24.008
Publication type: Paper in international publication
Authors: Zhang, Wenping, Bernard, John, de Bono, Johann, Chadjaa, Mustapha, Kacso, Gabriel, Font, Albert, Parente, Phillip, Eisenberger, Mario, Hardy-Bessard, Anne-Claire, Kim, Choung Soo et al.
DOI: 10.1200/JCO.2016.72.1076

Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA.

PMID: 28809610
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15.
Impact factor:
Publication type: Paper in international publication
Authors: Bernard, John; Carles, Joan; Chadjaa, Mustapha; de Bono, Johann; Eisenberger, Mario; Font, Albert; Ford, Daniel; Geczi, Lajos; Hardy-Bessard, Anne-Claire; Kacso, Gabriel et al.
DOI: 10.1200/JCO.2016.72.1076